BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
We re-initiate coverage on JB Chemicals and Pharmaceuticals Ltd. on a positive note due to its strong balance sheet as well as increasing focus towards the domestic business, which would help to generate better return ratios and cash flows as compared to other geographies, in our view.
Our optimism is further premised on the stock due to-
JB Chemicals' focus on the chronic segment in the domestic business, which contributes significantly to operating profits,
debt-free balance sheet,
lower capex requirements,
healthy return ratios, and
strong cash flows.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
